Nuclear receptors in liver fibrosis
Philipp Königshofer(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Philipp Schwabl(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Oleksandr Petrenko(Austrian Academy of Sciences), Ksenia Brusilovskaya(Austrian Academy of Sciences)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
July 30, 2021
Cited by 46
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399